RMD
ResMed Inc.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$228.35
−0.37%Forward multiples
Based on analyst estimates
- P/E forward
- 18.82x
- P/E 2026E
- 20.36x
- P/E 2027E
- 18.72x
- P/E 2028E
- 17.03x
- P/S forward
- 5.68x
Trailing multiples
Trailing twelve months
- P/E TTM
- 21.87x
- PEG TTM
- 1.34x
- Price / book
- 5.00x
- Price / sales
- 5.83x
- Price / cash flow
- 10.43x
Enterprise value
- Enterprise value
- $32.3B
- EV / sales
- 5.71x
- EV / EBITDA
- 15.05x
- EV / EBIT
- 17.06x
- Market cap
- $32.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026